Showing results (291-300 of 330) with videos related to
Sort By:
Pageof 33
Neurology|October 24, 2014
Determinants of antithrombotic choice for patent foramen ovale in cryptogenic strokeDavid E Thaler, Robin Ruthazer, Christian Weimar, et al.American Heart Journal|June 23, 2014
Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAnna Kotsia, Emmanouil S Brilakis, Claes Held, et al.BMC Evolutionary Biology|March 1, 2006
Molecular phylogeny and taxonomic revision of the sportive lemurs (Lepilemur, Primates)Nicole Andriaholinirina, Jean-Luc Fausser, Christian Roos, et al.Journal of Atrial Fibrillation|December 24, 2021
Left Atrial Appendage Occlusion Device Embolization (The LAAODE Study): Understanding the Timing and Clinical Consequences from a Worldwide ExperienceGhulam Murtaza, Mohit K Turagam, Tawseef Dar, et al.Circulation. Cardiovascular Imaging|November 12, 2013
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism databaseBenjamin S Wessler, David E Thaler, Robin Ruthazer, et al.European Heart Journal|October 26, 2018
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolismChristian Pristipino, Horst Sievert, Fabrizio D'Ascenzo, et al.JACC. Cardiovascular Interventions|February 25, 2017
Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac PlugJacqueline Saw, Apostolos Tzikas, Samera Shakir, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymerScot Garg, Giovanna Sarno, Patrick W Serruys, et al.Lancet (London, England)|November 15, 2011
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trialGiulio G Stefanini, Bindu Kalesan, Patrick W Serruys, et al.Lancet (London, England)|September 4, 2008
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trialStephan Windecker, Patrick W Serruys, Simon Wandel, et al.Pageof 33